FTC sues important pharmacy gain supervisors more than insulin costs The agency brought motion in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record cost of existence-conserving insulin prescription drugs. Before this summer time, the organization held lengthy negotiations with https://kethek.com/